drugset / Trial / NCT04498884
Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
RandomizedCrossoverDouble-blindBasic science
Summary
Pharmacokinetics and pharmacodynamics study of 2 formulations of insulin mixtures Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) versus Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France).
Timeline
- Start
- 2017-07-18
- Primary completion
- 2017-10-24
- Completion
- 2017-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Humulin® M3 | Unknown | 0.4 iu/kg | Subcutaneous |
| Subject | Rinsulin® mix 30/70 | Unknown | 0.4 iu/kg | Subcutaneous |
Indications
No indication recorded.